Naltrexone-mediated opiate detoxification: A matter of terminology!

Addiction Biology

Volumn 8, Issue 3, 2003, Pages 267-269

  Johnson, T S ^a   Carr, M ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMIDE; CLONIDINE; NALTREXONE; OCTREOTIDE; SCOPOLAMINE;

ABSTINENCE; CLINICAL PROTOCOL; DRUG DETOXIFICATION; DRUG WITHDRAWAL; EDITORIAL; HUMAN; NOMENCLATURE; OPIATE ADDICTION; PRIORITY JOURNAL; PROVOCATION TEST; SEDATION;

HUMANS; METABOLIC DETOXICATION, DRUG; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; TERMINOLOGY;

EID: 0141482045     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210310001613471     Document Type: Editorial

References (12)

1. Milby J, Gurwitch R, Hohmann A. Assessing pathological detoxification fear among methadone maintenance patients: the DFSS. J Clin Psychol 1987;43:528-38.
2. Brewer C, Maksoud NA. Opiate detoxification under anesthesia. JAMA 1997;278:1318.
3. Carreno JE, Bobes J, Brewer C et al. 24-hour opiate detoxification and antagonist induction at home - the 'Asturian method': a report on 1368 procedures. Addict Biol 2002;7:243-50.
4. Beaini AY, Johnson TS, Langstaff P et al. A compressed opiate detoxification regime with naltrexone maintenance: patient tolerance, risk assessment and abstinence rate. Addict Biol 2000;5:451-62.
5. Farrell M, Strang J. Compressed opiate withdrawal syndrome and naltrexone. J Psychopharmacol 1995;9:383-5.
6. Harris L. A comparison of buprenorphine with lofexadine in the rapid opiate detoxification of patients with opiate dependency in a community setting. Addict Biol 2003;8:243.
7. Reece AS. The case for naltrexone. Australian Family Association 2001; July:40.
8. Kirchmayer U et al. A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 2002;97:1241-9
9. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Systematic Review 2003; 2:CD001333.
10. Foster J, Brewer C, Steele T. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels. Addict Biol 2003;8:211-17.
11. Comer SD et al. Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology (Berlin) 2002;159:351-60.
12. Modesto-Lowe V. Naltrexone depot (Drug Abuse Sciences). Idrugs 2002;5:835-8.